We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
On April 2, 2009, the U.S. Food and Drug Administration (FDA) publicly released fourteen “untitled” letters to major pharmaceutical firms challenging the use of “sponsored links” and alleging that the links make product claims but fail to provide required risk information
